The Power of Research, The Promise of Hope
The Annual Hardesty Lecture featuring NCI Director Dr. Norman “Ned” Sharpless will be held on Thursday, October 18, at 4:00 p.m. in the Okey Patteson Auditorium. (This lecture will be webcast for those who can not attend in person.)
Norman E. “Ned” Sharpless, M.D., was officially sworn in as the 15th director of the National Cancer Institute (NCI) on October 17, 2017. Prior to his appointment, Dr. Sharpless served as the director of the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center, a position he held since January 2014.
Dr. Sharpless was a Morehead Scholar at UNC-Chapel Hill and received his undergraduate degree in mathematics. He went on to pursue his medical degree from the UNC School of Medicine, graduating with honors and distinction in 1993. He then completed his internal medicine residency at the Massachusetts General Hospital and a hematology/oncology fellowship at Dana-Farber/Partners Cancer Care, both of Harvard Medical School in Boston.
After 2 years on the faculty at Harvard Medical School, he joined the faculty of the UNC School of Medicine in the Departments of Medicine and Genetics in 2002. He became the Wellcome Professor of Cancer Research at UNC in 2012.
Dr. Sharpless is a member of the Association of American Physicians as well as the American Society for Clinical Investigation (ASCI), the nation’s oldest honor society for physician-scientists, and served on the ASCI council from 2011 to 2014. Dr. Sharpless was an associate editor of Aging Cell and deputy editor of the Journal of Clinical Investigation. He has authored more than 150 original scientific papers, reviews, and book chapters, and is an inventor on 10 patents. He co-founded two clinical-stage biotechnology companies: G1 Therapeutics and HealthSpan Diagnostics.
In addition to serving as Director of NCI, Dr. Sharpless continues his research in understanding the biology of the aging process that promotes the conversion of normal self-renewing cells into dysfunctional cancer cells. Dr. Sharpless has made seminal contributions to the understanding of the relationship between aging and cancer, and in the preclinical development of novel therapeutics for melanoma, lung cancer, and breast cancer.
Hardesty Lecture Series The WVU Cancer Institute proudly presents the annual Hardesty Lecture, established by David and Susan Hardesty. This special lecture series brings renowned cancer scientists and physicians to the WVU campus for the benefit of the University and the Morgantown community. The series is an opportunity to bring experts to campus and provide extensive interactions with graduate students, medical practitioners for workshops and informal engagements that foster growth and encourage curiosity. It was created as a tribute to this couple’s loyal devotion and outstanding service to their alma mater and their tremendous impact on the University’s growth and development.
Dental school's tobacco treatment training program will host its third continuing education course in May 2020.
WVU in the News: Industry cites 3M research on cancer patients exposed to PFOA to claim them chemical isn't so bad
Defenders of the chemicals known as PFAS have seized upon an industry-funded study of cancer patients as evidence that PFOA, the compound used to make Teflon, firefighting foam, and many other products, isn’t as dangerous as it seems.
Sumaira Shafi, M.D., has joined the hematology/oncology staff at Camden Clark Regional Cancer Center, a WVU Cancer Institute location.